Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyorin Rimedio Co., Ltd., formerly known as Toyo Pharmer Co., Ltd., is a Japanese pharmaceutical company that serves as the generic drug division of the Kyorin Pharmaceutical Group. Founded in 1947 and renamed Toyo Pharmer in 1971, the company was fully integrated into Kyorin Pharmaceutical in 2006 and adopted its current name in 2007. The company specializes in the development, manufacturing, and marketing of generic medicines, with a particular focus on authorized generics (AGs) which are identical to the original brand-name drugs. Its portfolio includes treatments for respiratory conditions, urological disorders, and allergies, such as generic versions of montelukast and mometasone. Headquartered in Kanazawa, Ishikawa Prefecture, Kyorin Rimedio leverages its research and development capabilities at the Takaoka Pharmaceutical Technology Innovation Center to provide high-quality, reliable healthcare products to the Japanese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toyo Pharmer.